Orthopediatrics (KIDS) Leases (2019 - 2022)
Orthopediatrics' quarterly Leases came in at $259000.0 in Q4 2022, down 12.79% year-on-year from $297000.0 in Q4 2021, and down 12.79% quarter-over-quarter from $297000.0 in Q4 2021.
Orthopediatrics has reported Leases for 3 years, with the latest figure at $259000.0 in Q4 2022.
- For the quarter ending Q4 2022, Leases fell 12.79% year-over-year to $259000.0; the trailing twelve-month figure through Dec 2022 stood at $259000.0 (down 12.79% YoY), and the FY2022 full-year result was $259000.0, down 12.79% from the prior year.
- Leases for Q4 2022 stood at $259000.0, down from $297000.0 in the prior quarter.
- The five-year high for Leases was $324000.0 in Q3 2021, with the low at $75000.0 in Q2 2019.
- Average Leases over 3 years is $261333.3, with a median of $296000.0 recorded in 2021.
- Peak annual rise in Leases reached 12.79% in 2022, while the deepest fall reached 12.79% in 2022.
- Tracing KIDS's Leases over 3 years: stood at $75000.0 in 2019, then soared by 296.0% to $297000.0 in 2021, then fell by 12.79% to $259000.0 in 2022.
- The last three Leases figures came in at $259000.0 (Q4 2022), $297000.0 (Q4 2021), and $324000.0 (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 547.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 99.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 73.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 396.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 155.20 Mn |
| 10 | Orthopediatrics | 394.83 Mn | 346.02 Mn | 43.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 259,000.00 |
| Dec 31, 2021 | 297,000.00 |
| Sep 30, 2021 | 324,000.00 |
| Jun 30, 2021 | 295,000.00 |
| Mar 31, 2021 | 318,000.00 |
| Jun 30, 2019 | 75,000.00 |